Stevens Christopher James 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Aug 6, 2025
Insider Transaction Report
Form 4
Stevens Christopher James
Chief Operating Officer
Transactions
- Award
Common Stock
2025-08-04+407,166→ 407,166 total - Award
Stock Option (Right to Buy)
2025-08-04+554,071→ 554,071 totalExercise: $3.07Exp: 2035-08-04→ Common Stock (554,071 underlying)
Footnotes (2)
- [F1]Holdings are Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on August 4, 2026, with the remaining shares vesting in equal quarterly installments over the following two years.
- [F2]This option represents a right to purchase a total of 554,071 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on August 4, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.